Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Harmony Biosciences Holdings, Inc. (HRMY) had Cash Flow from Investing Activities of $-46.44M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
$168.41M |
|
$26.61M |
|
$43.15M |
|
$125.26M |
|
$128.22M |
|
$40.20M |
|
$-0.51M |
|
$39.69M |
|
$39.69M |
|
$26.61M |
|
$26.61M |
|
$26.61M |
|
$26.61M |
|
$40.20M |
|
$45.82M |
|
59.47M |
|
60.37M |
|
$0.47 |
|
$0.46 |
|
| Balance Sheet Financials | |
$451.07M |
|
$0.37M |
|
$360.38M |
|
$811.45M |
|
$163.78M |
|
$178.57M |
|
$180.68M |
|
$344.46M |
|
$466.99M |
|
$329.88M |
|
$466.99M |
|
56.77M |
|
| Cash Flow Statement Financials | |
$219.39M |
|
|
Cash Flow from Investing Activities |
$-46.44M |
$-105.55M |
|
$244.53M |
|
$311.93M |
|
$67.40M |
|
$31.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.75 |
|
-- |
|
-- |
|
0.28 |
|
0.41 |
|
74.38% |
|
23.87% |
|
23.87% |
|
-- |
|
23.57% |
|
15.80% |
|
$219.07M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
8.05 |
|
2.27 |
|
39.62 |
|
5.70% |
|
8.07% |
|
3.28% |
|
4.12% |
|
$8.23 |
|
$3.63 |
|
$3.63 |
|